CRIS Current Research Information System

AVNET, SOFIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.726
AS - Asia 7.744
EU - Europa 5.525
Continente sconosciuto - Info sul continente non disponibili 472
SA - Sud America 459
AF - Africa 405
OC - Oceania 52
Totale 23.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.423
CN - Cina 2.470
SG - Singapore 1.967
VN - Vietnam 1.542
GB - Regno Unito 1.228
IT - Italia 932
DE - Germania 872
HK - Hong Kong 586
SE - Svezia 537
FR - Francia 355
IN - India 329
BR - Brasile 314
RU - Federazione Russa 264
NL - Olanda 246
CA - Canada 235
KR - Corea 218
UA - Ucraina 209
JP - Giappone 192
IE - Irlanda 189
FI - Finlandia 151
ZA - Sudafrica 132
AT - Austria 106
CI - Costa d'Avorio 106
BD - Bangladesh 90
CH - Svizzera 76
TG - Togo 70
EE - Estonia 65
BG - Bulgaria 58
AR - Argentina 56
SC - Seychelles 52
AU - Australia 49
IL - Israele 46
ID - Indonesia 43
BE - Belgio 41
PL - Polonia 40
ES - Italia 37
JO - Giordania 36
PH - Filippine 34
PK - Pakistan 31
TR - Turchia 28
GR - Grecia 25
MX - Messico 25
IQ - Iraq 23
EC - Ecuador 21
TH - Thailandia 21
LT - Lituania 18
PT - Portogallo 16
TW - Taiwan 16
CL - Cile 15
CO - Colombia 13
EG - Egitto 12
NO - Norvegia 12
PE - Perù 12
VE - Venezuela 12
HN - Honduras 10
MY - Malesia 9
PY - Paraguay 9
SA - Arabia Saudita 9
AE - Emirati Arabi Uniti 8
AL - Albania 8
UZ - Uzbekistan 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
DK - Danimarca 6
HU - Ungheria 6
LB - Libano 6
MA - Marocco 6
NG - Nigeria 6
DO - Repubblica Dominicana 5
HR - Croazia 5
IR - Iran 5
KE - Kenya 5
KZ - Kazakistan 5
QA - Qatar 5
RO - Romania 5
JM - Giamaica 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
BO - Bolivia 3
ET - Etiopia 3
LK - Sri Lanka 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
RS - Serbia 3
TN - Tunisia 3
DZ - Algeria 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
SV - El Salvador 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
Totale 22.897
Salva come PNG Salva come JPEG
Città #
Singapore 1.377
Southend 816
Ashburn 802
Fairfield 600
Chandler 535
Hong Kong 499
Santa Clara 483
Hefei 470
San Jose 376
Woodbridge 314
Ho Chi Minh City 313
Wilmington 298
Seattle 290
Houston 288
Ann Arbor 280
Hanoi 263
Los Angeles 257
Beijing 240
Princeton 238
Dong Ket 212
Cambridge 205
Council Bluffs 200
Seoul 184
Dublin 181
Bologna 166
Tokyo 164
Boardman 161
Nanjing 133
Jacksonville 132
Lauterbourg 124
Munich 119
Dallas 113
Helsinki 111
Abidjan 106
New York 97
Berlin 91
Westminster 86
Padova 79
Mcallen 77
Guangzhou 74
Montréal 74
Lomé 70
Boston 68
Vienna 67
Frankfurt am Main 65
Bern 63
Milan 63
Shanghai 61
Buffalo 59
Haiphong 57
Jinan 55
Saint Petersburg 55
Chicago 54
San Diego 54
Sofia 53
Da Nang 51
Tianjin 50
Johannesburg 49
Shenyang 44
Bengaluru 43
Toronto 41
Redondo Beach 39
Tuscaloosa 39
Florence 37
Hangzhou 37
Ypsilanti 37
Amman 36
Nanchang 36
Ottawa 36
Washington 35
Windsor 35
Brussels 34
Hebei 34
Zhengzhou 34
Medford 31
Changchun 30
Irvine 30
Nuremberg 30
Turin 30
London 29
Mülheim 29
Atlanta 28
Bremen 27
Warsaw 27
Changsha 26
Des Moines 26
Jakarta 26
Jerusalem 26
Phoenix 26
Porto Alegre 26
Wuhan 26
Ha Kwai Chung 25
Brisbane 24
São Paulo 23
Falkenstein 21
Fuzhou 21
Montreal 21
Paris 20
Raleigh 20
Amsterdam 19
Totale 13.886
Salva come PNG Salva come JPEG
Nome #
The human tumor microbiome is composed of tumor type-specific intracellular bacteria 2.543
Validation of Suitable Housekeeping Genes for the Normalization of mRNA Expression for Studying Tumor Acidosis 579
V-ATPase is a candidate therapeutic target for Ewing sarcoma 278
Abstract 5909: IDH mutations in G2-3 conventional chondrosarcoma of bone: a mono institutional experience 275
A novel biomaterial for osteotropic drug nanocarriers: synthesis and biocompatibility evaluation of a PLGA-ALE conjugate. 259
V-ATPase as an effective therapeutic target for sarcomas. 251
Altered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance 249
Exosome-like Nanovesicles Isolated from Citrus limon L. Exert Antioxidative Effect 232
Acid microenvironment promotes cell survival of human bone sarcoma through the activation of cIAP proteins and NF-κB pathway 229
Benign albeit glycolytic: MCT4 expression and lactate release in giant cell tumour of bone 226
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience 220
In vitro blockade of Receptor Activator of Nuclear factor kappa b ligand prevents osteoclastogenesis induced by neuroblastoma cells 218
Acid-Induced Inflammatory Cytokines in Osteoblasts: A Guided Path to Osteolysis in Bone Metastasis 218
Bone on-a-chip: a 3D dendritic network in a screening platform for osteocyte-targeted drugs 217
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. 216
Biocompatibility of poly(D,L-lactide-co-glycolide) nanoparticles conjugated with alendronate 215
Strawberry-derived exosome-like nanoparticles prevent oxidative stress in human mesenchymal stromal cells 215
Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation 210
Uncovering the protective role of lipid droplet accumulation against acid-induced oxidative stress and cell death in osteosarcoma 205
Cause and effect of microenvironmental acidosis on bone metastases 204
Prominent role of RAB39A-RXRB axis in cancer development and stemness 201
Incorporation/Enrichment of 3D Bioprinted Constructs by Biomimetic Nanoparticles: Tuning Printability and Cell Behavior in Bone Models 197
The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells 194
Osteoblasts from a mandibuloacral dysplasia patient induce human blood precursors to differentiate into active osteoclasts. 192
Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment 192
Identification and validation of housekeeping genes for gene expression analysis of cancer stem cells 190
Endogenous extracellular matrix regulates the response of osteosarcoma 3D spheroids to doxorubicin 186
New advances in the study of bone tumors: A lesson from the 3D environment 186
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Cancer Metabolism 184
Exploring metabolic adaptations to the acidic microenvironment of osteosarcoma cells unveils sphingosine 1-phosphate as a valuable therapeutic target 183
Impairment of lysosomal activity as a therapeutic modality targeting cancer stem cells of embryonal rhabdomyosarcoma cell line RD. 182
MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases 182
Tumor-activated mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion 181
Contribution of mitochondrial activity to doxorubicin-resistance in osteosarcoma cells 180
3d printing and bioprinting to model bone cancer: The role of materials and nanoscale cues in directing cell behavior 180
The effect of extracellular acidosis on the behaviour of mesenchymal stem cells in vitro 179
Histogenetic characterization of giant cell tumor of bone 178
The Effects of Systemic and Local Acidosis on Insulin Resistance and Signaling 178
FT-IR Spectral Signature of Sensitive and Multidrug-Resistant Osteosarcoma Cell-Derived Extracellular Nanovesicles 177
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells. 177
Spheroid-based 3D cell cultures identify salinomycin as a promising drug for the treatment of chondrosarcoma 177
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles 176
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. 176
In vitro study of human osteoclast activity on poli(epsilon-caprolactone) as a bone substitute biomaterial 174
Acid microenvironment in bone sarcomas 174
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. 171
Cathepsin k antisense inhibition of cell polarization and bone resorption in human osteoclast 170
Acridine Orange is an Effective Anti-Cancer Drug that Affects Mitochondrial Function in Osteosarcoma Cells 169
Energy metabolism in osteoclast formation and activity 169
Electrospun fibers coated with nanostructured biomimetic hydroxyapatite: A new platform for regeneration at the bone interfaces 167
Pre-clinical Models for Studying the Interaction between Mesenchymal Stromal Cells and Cancer Cells and the Induction of Stemness 167
In vitro effects of an antisense oligonucleotide targeting fgf-2 on renal carcinoma cells metastasizing to bone 166
Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells 166
The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation 166
Insulin receptor isoforms are differently expressed during human osteoblastogenesis. 164
Mesenchymal stromal cell adhesion and proliferation on ion-irradiated and RGD-modified polymer substrates 163
Elevated serum activity of TRACP5B in osteosarcoma patients (OS) is associated with an aggressive phenotype and with OS induced osteoclast activity 161
Curcumin-loaded nanoparticles impair the pro-tumor activity of acid-stressed msc in an in vitro model of osteosarcoma 160
Modulation of TGFbeta 2 levels by lamin A in U2-OS osteoblast-like cells: understanding the osteolytic process triggered by altered lamins. 159
Mesenchymal Stem Cells-Derived Small Extracellular Vesicles and Their Validation as a Promising Treatment for Chondrosarcoma in a 3D Model in Vitro 158
Antagonizing the S1P-S1P3 Axis as a Promising Anti-Angiogenic Strategy 158
Osteoclast differentiation from human blood precursors on biomimetic calcium-phosphate substrates 158
Mesenchymal stroma drives axonogenesis and nerve-induced aggressiveness in osteosarcoma 156
A Novel Microfluidic Platform for Personalized Anticancer Drug Screening Through Image Analysis 156
Effects of prelamin A processing inhibitors on the differentiation and activity of human osteoclasts. 156
Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas 156
Mesenchymal stroma: Role in osteosarcoma progression 155
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. 155
Automated Detection of Spinal Lesions From CT Scans via Deep Transfer Learning 154
Metabolism and microenvironment in cancer plasticity 154
Annual meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic networks in cancer 153
Sarcoma treatment in the era of molecular medicine 153
The Effect of Poly(d,l-Lactide-co-Glycolide)-Alendronate Conjugate Nanoparticles on Human Osteoclast Precursors. 152
Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. 150
Serum markers of loosening in patients with THA 149
Role of IGF-IR in osteoclast biology and differentiation 149
Annual Meeting of the International Society of Cancer Metabolism (ISCaM): Metabolic Adaptations and Targets in Cancer 149
Individual Trajectories of Bone Mineral Density Reveal Persistent Bone Loss in Bone Sarcoma Patients: A Retrospective Study 148
Height and pathogenesis of osteosarcoma 148
Radiodynamic Therapy with Acridine Orange Is an Effective Treatment for Bone Metastases 147
Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy. 147
Spontaneous Formation of Multinucleated Giant Cells with Bone Resorbing Activity by Long Culture of Human Peripheral Blood CD14-Positive Monocytes In Vitro. 144
in vitro effects of interferon-alpha on different cellular elements existing in a bone metastasis of renal cell carcinoma 143
Stromal cells derived from giant cell tumor of bone show osteoblast-like feature 143
Photodynamic Surgery for Feline Injection-Site Sarcoma 140
Bond Strength and Ultramorphological Evaluation After Simplified Immediate Dentin Sealing 138
Cytoskeletal disorganization in human osteoclasts following cathepsin K down-regulation 138
Therapeutic implications of tumor interstitial acidification 137
Perfused Platforms to Mimic Bone Microenvironment at the Macro/Milli/Microscale: Pros and Cons 136
The release of inflammatory mediators from acid-stimulated mesenchymal stromal cells favours tumour invasiveness and metastasis in osteosarcoma 134
IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors. 133
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study. 133
Study on the in vitro effect of platelet rich plasma on bone endothelial cells and on osteoclast differentiation for maxillo-facial surgery 131
Unravelling the Effect of Citrate on the Features and Biocompatibility of Magnesium Phosphate-Based Bone Cements 131
Behavioral Voluntary and Social Bioassays Enabling Identification of Complex and Sex-Dependent Pain-(-Related) Phenotypes in Rats with Bone Cancer 130
Role of Pericellular Matrix in the Regulation of Cancer Stemness 129
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells 128
The natural compound Alizarin as an osteotropic drug for the treatment of bone tumors. 126
Sustained Autocrine Induction and Impaired Negative Feedback of Osteoclastogenesis in CD14(+) Cells of Giant Cell Tumor of Bone 126
Epigenetic Regulation Mediated by Sphingolipids in Cancer 125
Totale 20.059
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.562
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.562
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.058 0 84 147 165 158 123 58 153 78 237 463 392
2022/20232.358 244 341 129 265 177 177 69 152 371 55 202 176
2023/2024659 81 111 57 51 50 131 27 33 16 54 31 17
2024/20253.187 90 438 216 248 566 199 155 115 30 287 214 629
2025/20269.083 649 745 693 624 1.171 606 953 494 1.692 725 406 325
2026/2027773 401 372 0 0 0 0 0 0 0 0 0 0
Totale 23.383